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Background: Rodenticide poisoning remains a major public health problem in Asian countries. Nevertheless, very
few data are available in world literature regarding the outcomes of these patients. Therefore, the purpose of this
study was to investigate the clinical outcomes of rodenticide poisonings in our hospital and to compare these data
with published reports from other international poison centers.
Findings: We retrospectively examined the records of 20 patients with rodenticide poisoning (8 brodifacoum,
12 bromadiolone) who were referred to Chang Gung Memorial Hospital between 2000 and 2011. It was found
that most of the rodenticide patients were middle-aged adults. Both genders were equally affected and many
patients had a past history of major depressive disorder or schizophrenia. Nevertheless, patients with bromadiolone
were referred significantly sooner than patients with brodifacoum poisoning (0.1 ± 0.1 versus 5.5 ± 10.5, P < 0.001).
Furthermore, it was found that patients with brodifacoum suffered higher incidences of ecchymosis (50.0% versus 0%,
P = 0.006) and hematuria (50.0% versus 0%, P = 0.006) than patients with bromadiolone poisoning. Laboratory analysis
also demonstrated a poorer hemostatic profile of patients with brodifacoum [prothrombin time (PT), international
normalized ratio (INR), 4.3 ± 4.8 versus 1.0 ± 0.1, P = 0.032; PT prolongation, 50.0% versus 0%, P = 0.006; activated partial
thromboplastin time (aPTT) prolongation, 50.0% versus 0%, P = 0.006] than patients with bromadiolone poisoning.
At the end of analysis, no patient died of the poisoning.
Conclusion: The favorable outcome (zero mortality rate) is comparable to the published reports from other
international poison centers. Further studies are warranted.
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Superwarfarin rodenticide consists of two classes of com-
pounds, the 4-hydroxycoumarins and the indandiones
(Gunja et al. 2011). These compounds have replaced
warfarin as an anticoagulant rodenticide. Given that
the 4-hydroxycoumarin derivatives brodifacoum and
bromadiolone are now the most frequently used roden-
ticides in Taiwan, they also account for the majority of
rodenticide poisonings reported to our poison center.
Both brodifacoum and bromadiolone act by the same
mechanism as warfarin but are 100 times more potent
and have much longer serum and tissue half-lives (Park* Correspondence: m19570@adm.cgmh.org.tw
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in any medium, provided the original work is pand Leck 1982). Coagulation factors II, VII, IX, X, and
other vitamin K–dependent proteins require gamma-
carboxylation of glutamic acid residues to be biologically
active. In the carboxylation reaction, the cofactor vitamin
K is converted to an inactive vitamin K-2,3-epoxide.
Active vitamin K is regenerated by epoxide reductase
enzymes, which are blocked by warfarin and its analogs
(Furie et al. 1999). The limited availability of active vita-
min K produces a bleeding diathesis or complication.
The increased efficacy of superwarfarins as rodenticides
results from their high lipid solubility, affinity for hepatic
tissue and slow elimination from the body. The treatment
of poisoned patients includes gastric lavage, followed by
infusion of active charcoal, vitamin K1 therapy, and FFP
transfusion in the case of bleeding (Caravati et al. 2007).
Rodenticide poisoning remains a major public health
problem in Asian countries. Nevertheless, very few datapen Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
Yu et al. SpringerPlus 2013, 2:505 Page 2 of 6
http://www.springerplus.com/content/2/1/505are available in literature regarding the outcomes of
these patients. Therefore, the purpose of this study was
to investigate the clinical outcomes of these poisonings
in our hospital and to compare these data with published
reports from other international poison centers.Materials and methods
Ethics
This retrospective observational study complied with the
guidelines of the Declaration of Helsinki and was ap-
proved by the Medical Ethics Committee of Chang Gung
Memorial Hospital, a tertiary referral center located in
the northern part of Taiwan. All primary data were col-
lected according to the Strengthening the Reporting of
Observational Studies in Epidemiology guidelines.Patients
We examined the records of 20 patients with rodenticide
poisoning who were examined at Chang Gung Memorial
Hospital between 2000 and 2011. Demographic, clinical
and laboratory data were collected, and the mortality rate
was analyzed. Diagnosis of rodenticide intoxication was
based on exposure history, and confirmed by clinical man-
ifestations as well as physical and laboratory examination.Inclusion and exclusion criteria
All patients who were diagnosed with rodenticide poisoning
at Chang Gung Memorial Hospital between 2000 and 2011
were eligible for inclusion in this study. The type of roden-
ticide was verified by container or packaging information.
Patients were excluded if the type of toxin swallowed was
unknown even if there was a clinical suspicion of rodenti-
cide intoxication. Finally, patients with co-ingestants or
physical injury were also excluded from this analysis.Detoxification protocol
The protocols used to treat patients included gastric lavage
(in case of within 4 hours of exposure), followed by infusion
of 1 g/kg activated charcoal and 250 mL magnesium citrate
via nasogastric tube. Magnesium citrate was used to pre-
vent constipation after charcoal administration. At our
hospital, the treatment of rodenticide poisoning was to
administer vitamin K1 via an intramuscular route because
the oral form of vitamin K1 was unavailable. Intravenous
vitamin K1 infusion was avoided if possible due to the risk
of anaphylaxis with this route of administration. Acute
doses of prophylactic vitamin K were also given at emer-
gency department to patients with a known ingestion of
rodenticide who was asymptomatic, but the antidote was
discontinued as soon as confirmation of no coagulopathy
or bleeding. Finally, a transfusion of FFP was indicated for
patients with active bleeding.Definitions of clinical events
An ecchymosis was defined as a subcutaneous purpura
of larger than 1 cm. A subconjunctival hemorrhage
was defined as a bleeding underneath the conjunctiva.
Hypotension was defined as a systolic blood pressure
of less than 90 mmHg or diastolic blood pressure of less
than 60 mmHg. Melena was defined as the discharge
of black, tarry, bloody stools, usually resulting from a
hemorrhage in the alimentary tract. Hematuria was de-
fined as presence of blood in the urine. Prolongation of
the PT and aPTT were based on an INR value >1.5
(Stanworth et al. 2011), or aPTT value of > 1.5 times
(Eby 1997) the laboratory mean control.Statistical analysis
Continuous variables are expressed as means and standard
deviations and categorical variables as numbers with per-
centages in brackets. All data were tested for normality
of distribution and equality of standard deviations be-
fore analysis. For comparisons between patient groups,
we used Student’s t test for quantitative variables and
Chi-square or Fisher’s exact tests for categorical variables.
We considered results that rejected the null hypothesis
with 95% confidence to be significant. All analyses were
performed with IBM SPSS Statistics Version 20.Results
Most of the rodenticide patients were middle-aged adults
(Table 1). Both genders were equally affected and many
patients had a past history of major depressive disorder
or schizophrenia. Furthermore, it was found that patients
with bromadiolone were referred significantly sooner
than patients with brodifacoum poisoning (0.1 ± 0.1 versus
5.5 ± 10.5 hours, P < 0.001).
Reported bleeding events included ecchymosis, subcon-
junctival hemorrhage, melena, and hematuria (Table 2).
Some patients also complained of acute gastrointestinal
symptoms, for example nausea, vomiting, abdominal dis-
tension, abdominal pain, etc. After analysis, it was revealed
that patients with brodifacoum suffered higher incidences
of bleeding complications, such as ecchymosis (50.0% versus
0%, P = 0.006) and hematuria (50.0% versus 0%, P = 0.006),
than patients with bromadiolone poisoning (Table 2).
Furthermore, laboratory analysis also demonstrated poorer
hemostatic profiles for patients with brodifacoum (PT, INR,
4.3 ± 4.8 versus 1.0 ± 0.1, P = 0.032; PT prolongation, 50.0%
versus 0%, P = 0.006; aPTT prolongation, 50.0% versus
0%, P = 0.006) than patients with bromadiolone poison-
ing (Table 3).
As shown in Table 4, there were no significant differ-
ences in treatment modalities between these two groups.
Finally, none of the patients died of the poisoning.
Table 1 Baseline characteristics of patients with brodifacoum and bromadiolone rodenticide poisoning (N = 20)
Variable Bromadiolone (N = 12) Brodifacoum (N = 8) P value
Age, year 37.3 ± 25.7 32.3 ± 17.7 0.639
Female, n (%) 6 (50.0) 5 (62.5) 0.582
Intentional, n (%) 9 (75) 7 (87.5) 0.494
Diabetes mellitus, n (%) 2 (16.7) 0 (0) 0.224
Hypertension, n (%) 3 (25.0) 0 (0) 0.125
Major depressive disorder and schizophrenia, n (%) 8 (66.7) 7 (87.5) 0.292
Alcohol consumption, n (%) 6 (50.0) 1 (12.5) 0.085
Smoking habit, n (%) 5 (41.7) 3 (37.5) 0.852
Betel nut chewing, n (%) 4 (33.3) 0 (0) 0.068
Therapeutic use of warfarin or antiplatelet drugs 0 (0) 0 (0) 1.000
Time elapsed between poisoning and hospital arrival, hour 0.1 ± 0.1 5.5 ± 10.5 <0.001***
Note: ***P < 0.001.
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There was no mortality in this study. The favorable out-
come, shown in Table 4, is comparable to that of pub-
lished reports from other international poison centers
(Table 5), whose the mortality rate was also 0%.
Nonetheless, there are few original studies reporting
outcomes of bromadione poisoning in the literature. In
1998, Chua and Friedenberg (1998) reported 11 cases of
superwarfarin poisoning from northern Wisconsin, USA.
All 7 children had accidentally ingested superwarfarin, 2
adults had Munchausen syndrome, and 1 teenager and 1
adult had attempted suicide using superwarfarin. Nine
of the 11 cases had taken brodifacoum. None of the pa-
tients died. In another study (Ingels et al. 2002), Ingels
et al. prospectively examined 595 children younger than
6 years of age who reported to the California Poison
Control System with acute unintentional superwarfarinTable 2 Clinical manifestations of patients with brodifacoum
Variable Bromadiolone (N = 1
Body temperature, °C 36.1 ± 0.5
Pulse rate, per minute 87.9 ± 21.4
Respiratory rate, per minute 19.1 ± 2.1
Systolic pressure, mmHg 148.4 ± 39.7
Diastolic pressure, mmHg 80.3 ± 16.8
Ecchymosis, n (%) 0 (0)
Subconjunctival hemorrhage, n (%) 0 (0)
Hypotension, n (%) 0 (0)
Nausea, n (%) 1 (8.3)
Vomiting, n (%) 2 (16.7)
Abdominal distension, n (%) 0 (0)
Abdominal pain, n (%) 4 (33.3)
Melena, n (%) 1 (8.3)
Hematuria, n (%) 0 (0)
Note: *P < 0.05, **P < 0.01.ingestions. None of the patients had clinically important
coagulopathy. Two patients had an INR of 1.5 or greater
(1.5 and 1.8) without symptoms. Single nosebleeds were
reported in another 2 patients with normal 48-hour INRs.
Another child had a small amount of blood crusted in
the nose with no other symptoms and no laboratory
work available. One child with a normal 48-hour INR
had blood-streaked stools that were thought to be caused
by an anal fissure. However, the proportion of patients
taking brodifacoum was not described. In another study
(Shepherd et al. 2002), the American Association of
Poison Control Centers (AAPCC) data from 1993 to 1996
were retrospectively reviewed for acute, unintentional
brodifacoum exposures in children aged 6 years and
younger. The analysis found 10,762 cases that involved
single, acute, unintentional ingestions of brodifacoum.
In this cohort, there were no deaths or major effectsand bromadiolone rodenticide poisoning (N = 20)
2) Brodifacoum (N = 8) P value
36.5 ± 1.1 0.331
98.4 ± 24.1 0.333
21.0 ± 2.4 0.098
114.6 ± 24.2 0.049*










Table 3 Laboratory findings of patients with brodifacoum and bromadiolone rodenticide poisoning (N = 20)
Variable Bromadiolone (N = 12) Brodifacoum (N = 8) P value
Blood test
Red blood cell, ×106//uL 4.5 ± 0.6 4.2 ± 1.3 0.422
Hemoglobin 13.1 ± 2.2, g/dL 12.0 ± 3.6 0.382
Platelet, 1000/uL 233.8 ± 62.4 257.1 ± 140.5 0.616
White blood cell, 1000/uL 6.9 ± 1.7 11.3 ± 9.7 0.143
Neutrophils, % 61.7 ± 12.7 59.6 ± 21.2 0.786
Aspartate aminotransferase, U/L 31.4 ± 17.1 28.5 ± 5.9 0.702
Alanine aminotransferase, U/L 28.6 ± 23.2 28.0 ± 29.1 0.962
Albumin, g/dL 4.0 ± 0.4 4.3 ± 0.4 0.343
Total bilirubin, mg/dL 0.7 ± 0.1 0.6 ± 0.1 0.468
Blood urea nitrogen, mg/dL 10.5 ± 4.8 13.1 ± 6.7 0.475
Creatinine, mg/dL 0.7 ± 0.3 0.8 ± 0.2 0.827
Calcium, mg/dL 9.1 ± 0.8 8.9 ± 0.6 0.730
Phosphate, mg/dL 4.0 ± 1.1 2.8 ± 0.2 0.416
Sodium, mEq/L 142.9 ± 2.5 143.2 ± 3.5 0.861
Potassium, mEq/L 4.0 ± 0.3 4.0 ± 0.3 1.000
Chloride, mEq/L 110.5 ± 7.8 108.0 ± 4.2 0.728
Glucose, mg/L 107.7 ± 34.8 110.0 ± 7.1 0.935
Cholesterol, mg/dL 135.5 ± 21.9 210.0 ± 21.0 0.220
Triglyceride, mg/dL 207.0 ± 41.0 502.0 ± 50.2 0.081
C-reactive protein mg/L 16.1 ± 1.6 7.1 ± 11.4 0.562
PT, INR 1.0 ± 0.1 4.3 ± 4.8 0.032*
PT prolongation, n (%) 0 (0) 4 (50) 0.006**
aPTT, n (%) 0 (0) 4 (50) 0.006**
Urine test
Blood, n (%) 0 (0) 5 (62.5) 0.004**
Red blood cell, per HPF 0 ± 0 217.6 ± 264.3 0.206
Stool test
Occult blood, n (%) 1 (8.3) 1 (12.5) 0.910
Note: Activated partial thromboplastin time, HPF high power field, INR International normalized ratio, PT Prothrombin time *P < 0.05, **P < 0.01.
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coagulopathy, no major effects or deaths were reported.
Minor and moderate effects were reported in 38 and 54
children, respectively. Approximately half of all the
children received some form of gastrointestinal decon-
tamination, which had no effect on the distribution ofTable 4 Treatment outcomes of patients with brodifacoum an
Variable Bromadiolon
Gastric lavage, n (%) 7 (58.3)
Active charcoal and magnesium citrate, n (%) 6 (50.0)
Vitamin K1, n (%) 10 (83.3)
FFP, n (%) 0 (0)
Mortality, n (%) 0 (0)
Note: FFP Fresh frozen plasma.outcomes but which caused adverse effects in 42 patients.
In another study (Wu et al. 2009), Wu et al. studied 9
Taiwanese cases of superwarfarin poisoning at the Changhua
Christian Hospital, seven of which were brodifacoum in-
toxication. Of the 9 patients, hematuria occurred in eight.
Laboratory tests showed extremely prolonged PT andd bromadiolone rodenticide poisoning (N = 20)






Table 5 Comparison of clinical outcome between current and published studies (sample size > 5) from different
geographic areas
Study Year Area Sample size Proportion of brodifacoum Outcome Mortality rate
Chua and Friedenberg (1998) 1998 USA 11 Brodifacoum (9/11) Ecchymosis (1/11) 0
Hematuria (1/11)
Ingels et al. (2002) 2002 USA 545 Not reported Not reported 0
Shepherd et al. (2002) 2002 USA 10762 Brodifacoum (10762/10762) Not reported 0
Wu et al. (2009) 2009 Taiwan 9 Brodifacoum (7/9) Ecchymosis (5/9) 0
Hematuria (8/9)
Hong et al. (2010) 2010 Korea 10 Brodifacoum (5/10) Ecchymosis (4/10) 0
Hematuria (4/10)
Current study 2011 Taiwan 20 Brodifacoum (8/20) Ecchymosis (4/20) 0
Hematuria (4/20)
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with normal pooled plasma; they also had very low func-
tional levels of factor II, VII, IX, X, and proteins C and S,
but normal functional levels of factors V, VIII, fibrinogen,
and anti-thrombin III. Large doses of vitamin K1 were
needed for 3 months or more to treat and correct the
coagulopathy among the patients. The majority of the
patients presented with gross hematuria, and thus required
prolonged use of large doses of vitamin K1 for the treat-
ment of superwarfarin intoxication. Finally, Hong et al.
(Hong et al. 2010) found 10 Korean patients diagnosed
as or highly suspicious for superwarfarin intoxication at
Gachon University Gil Hospital. Bleeding symptoms
varied among the patients and patients uniformly showed
prolonged PT and aPTT with decreased activity of vita-
min K dependent coagulation factors. Positive serum
brodifacoum test results in 4 of 5 requested patients
contributed to confirmatory diagnosis. High dose vita-
min K1 therapy promptly corrected the prolonged PT
and aPTT, but hasty discontinuation caused repeated
bleeding diathesis in 6 patients. Therefore, high dose and
prolonged use of vitamin K1 therapy was necessary for
effective detoxification.
In this study, it was found that patients with
brodifacoum suffered higher incidences of bleeding com-
plications, such as ecchymosis (P = 0.006) and hematuria
(P = 0.006), than patients with bromadiolone poisoning
(Table 2). Previous laboratory studies also indicated that
the acute lethal dose 50 (LD50) for these two rodenti-
cides were quite different. For example, the acute LD50
of brodifacoum for various animals were rats 0.27-
0.30 mg/kg body weight (bw), mice 0.40 mg/kg bw,
rabbits 0.30 mg/kg bw, guinea-pigs 0.28 mg/kg bw,
cats 25 mg/kg bw and dogs 0.25-3.6 mg/kg bw (Brodifacoum
Web 2013); on the other hand, the acute LD50 of
bromadiolone for various animals were rats 1.125 mg/kg bw,
mice 1.75 mg/kg bw, rabbits 1 mg/kg bw, dogs >10 mg/kg
bw and cats >25 mg/kg bw (Bromadiolone Web 2013).Another consideration is the speedy of hospital referral.
In this study, it was found that patients with bromadiolone
were referred significantly sooner than patients with
brodifacoum poisoning (Table 1). Therefore, it seems
reasonable to consider that patients who present very
soon after oral exposure and who receive aggressive gas-
tric decontamination procedures would be less likely to
develop clinical signs and symptoms of the exposure
when compared to a group that have delayed presenta-
tion to the emergency department and delays in receiv-
ing gastric emptying treatments.
There were only 20 cases of rodenticide poisonings
discovered over a period of 11 years (Table 1). In contrast
to numerous cases of poisonings due to other toxins (Yang
et al. 2012; Liu et al. 2012; Lin et al. 2012; Lin et al. 2011),
the data indicate that rodenticide exposure in Taiwan is
relatively uncommon. Similarly, Berny et al. (Berny et al.
2010) also found that the number of anticoagulant expo-
sures reported to the Lyon Poison Control Center was
very limited. This might be the result of the addition
of bittering agents (Mason et al. 1985) into the formu-
lations of rodenticides, which make them less tasty.
Similarly, this might help explain why most of the ro-
denticide cases were also sufferers of major depressive
disorders or schizophrenia (Table 1); because these pa-
tients often had distorted perception of reality.
In conclusion, the data is important because it is one
of few original reports on Asian patients with rodenticide
poisoning. Furthermore, the favorable outcome (zero mor-
tality rate) is comparable to the published reports from
other international poison centers. Nevertheless, the retro-
spective nature of the study, the small patient population,
and the short follow-up duration are limitations that
warrant further investigations to validate the conclusion
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